Israel & USA team up to fight cancer

Israeli biotech Compugen has enlisted John Hopkins University to help assess Compugen’s cancer immunotherapy candidates.  These new treatments aim to counter the ability of tumors to highjack “immune checkpoints”, thereby blocking the immune system’s ability to destroy the tumor.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *